Depression Amongst HIV Positive Patients in Lilongwe

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

206 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-05-31

Study Completion Date

2013-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Quantitative, validated tools of depression screening will be used to collect data to determine the prevalence of depression and its association with antiretroviral (ARV) adherence amongst HIV positive patients attending ART clinic at Lighthouse Lilongwe, Malawi.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Examining HIV Treatment Adherence During Early Disease

NCT02419066

Medication Adherence HIV

COMPLETED

Advanced HIV Disease During the First Six Months on Antiretroviral Therapy in Zambia

NCT06904456

Advanced HIV Disease

RECRUITING

UNCPM 22322 - Adaption of the Transition of Care Model for Post-Discharge HIV-NCD Care in Lilongwe, Malawi - MLATHO

NCT06931431

HIV Noncommunicable Diseases

RECRUITING NA

Cognitive Behavioral Therapy on Adherence and Depression (CBT-AD) Among HIV/AIDS Patients

NCT06109610

Depression Medication Adherence

UNKNOWN NA

Pre-ART Retention in Care in Tanzania

NCT01992887

HIV (Human Immunodeficiency Virus) AIDS (Acquired Immunodeficiency Syndrome)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Preliminary data on prevalence and associations will be collected from 200 HIV positive adult men and women attending ART clinic at the Lighthouse in Lilongwe, Malawi. Quantitative, validated tools of depression screening will be used. A short structured demographic questionnaire will be used to collect demographic data. For depression, a Patient Health Questionnaire (PHQ) will be used while alcohol use will be assessed by Alcohol Use Disorders Identification Test (AUDIT) screening tool. The data collected will provide baseline data planning, program development and evaluation, and to promote comprehensive care provision for the people living with AIDS attending ART clinics in Malawi.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV AIDS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients initiating ART

HIV positive men and women initiating ART

depression screening

Intervention Type OTHER

Patient Health Questionnaire

patients on established ART

HIV positive men and women on established ART

depression screening

Intervention Type OTHER

Patient Health Questionnaire

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

depression screening

Patient Health Questionnaire

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years and above
* HIV positive men and women accessing care at LH
* Both ART naïve and on ART
* Registered with LH
* Receiving primary care and/ or ART from LH